278 related articles for article (PubMed ID: 17875631)
21. Protein expression profiling of Coccidioides posadasii by two-dimensional differential in-gel electrophoresis and evaluation of a newly recognized peroxisomal matrix protein as a recombinant vaccine candidate.
Orsborn KI; Shubitz LF; Peng T; Kellner EM; Orbach MJ; Haynes PA; Galgiani JN
Infect Immun; 2006 Mar; 74(3):1865-72. PubMed ID: 16495561
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of antigen 2/proline-rich antigen cDNA-transfected dendritic cells in immunization of mice against Coccidioides posadasii.
Awasthi S; Awasthi V; Magee DM; Coalson JJ
J Immunol; 2005 Sep; 175(6):3900-6. PubMed ID: 16148136
[TBL] [Abstract][Full Text] [Related]
23. Preclinical identification of vaccine induced protective correlates in human leukocyte antigen expressing transgenic mice infected with Coccidioides posadasii.
Hurtgen BJ; Castro-Lopez N; Jiménez-Alzate MDP; Cole GT; Hung CY
Vaccine; 2016 Oct; 34(44):5336-5343. PubMed ID: 27622300
[TBL] [Abstract][Full Text] [Related]
24. Dendritic cell-based immunization induces Coccidioides Ag2/PRA-specific immune response.
Awasthi S; Vilekar P; Conkleton A; Rahman N
Vaccine; 2019 Mar; 37(12):1685-1691. PubMed ID: 30795939
[TBL] [Abstract][Full Text] [Related]
25. Th1-type immune response to a Coccidioides immitis antigen delivered by an attenuated strain of the non-invasive enteropathogen Vibrio cholerae.
Silva AJ; Benitez JA
FEMS Immunol Med Microbiol; 2005 Mar; 43(3):393-8. PubMed ID: 15708313
[TBL] [Abstract][Full Text] [Related]
26. Improved protection of mice against lethal respiratory infection with Coccidioides posadasii using two recombinant antigens expressed as a single protein.
Shubitz LF; Yu JJ; Hung CY; Kirkland TN; Peng T; Perrill R; Simons J; Xue J; Herr RA; Cole GT; Galgiani JN
Vaccine; 2006 Jul; 24(31-32):5904-11. PubMed ID: 16759762
[TBL] [Abstract][Full Text] [Related]
27. Glucan-Chitin Particles Enhance Th17 Response and Improve Protective Efficacy of a Multivalent Antigen (rCpa1) against Pulmonary Coccidioides posadasii Infection.
Hung CY; Zhang H; Castro-Lopez N; Ostroff GR; Khoshlenar P; Abraham A; Cole GT; Negron A; Forsthuber T; Peng T; Galgiani JN; Ampel NM; Yu JJ
Infect Immun; 2018 Nov; 86(11):. PubMed ID: 30104216
[TBL] [Abstract][Full Text] [Related]
28. An agonist of human complement fragment C5a enhances vaccine immunity against Coccidioides infection.
Hung CY; Hurtgen BJ; Bellecourt M; Sanderson SD; Morgan EL; Cole GT
Vaccine; 2012 Jun; 30(31):4681-90. PubMed ID: 22575167
[TBL] [Abstract][Full Text] [Related]
29. Both CD4+ and CD8+ T cells can mediate vaccine-induced protection against Coccidioides immitis infection in mice.
Fierer J; Waters C; Walls L
J Infect Dis; 2006 May; 193(9):1323-31. PubMed ID: 16586371
[TBL] [Abstract][Full Text] [Related]
30. Maize-Produced Ag2 as a Subunit Vaccine for Valley Fever.
Hayden CA; Hung CY; Zhang H; Negron A; Esquerra R; Ostroff G; Abraham A; Lopez AG; Gonzales JE; Howard JA
J Infect Dis; 2019 Jul; 220(4):615-623. PubMed ID: 31184702
[TBL] [Abstract][Full Text] [Related]
31. In vivo trafficking and immunostimulatory potential of an intranasally-administered primary dendritic cell-based vaccine.
Vilekar P; Awasthi V; Lagisetty P; King C; Shankar N; Awasthi S
BMC Immunol; 2010 Dec; 11():60. PubMed ID: 21143974
[TBL] [Abstract][Full Text] [Related]
32. Vaccinated C57BL/6 mice develop protective and memory T cell responses to Coccidioides posadasii infection in the absence of interleukin-10.
Hung CY; Castro-Lopez N; Cole GT
Infect Immun; 2014 Feb; 82(2):903-13. PubMed ID: 24478103
[TBL] [Abstract][Full Text] [Related]
33. CARD9-Associated Dectin-1 and Dectin-2 Are Required for Protective Immunity of a Multivalent Vaccine against
Campuzano A; Zhang H; Ostroff GR; Dos Santos Dias L; Wüthrich M; Klein BS; Yu JJ; Lara HH; Lopez-Ribot JL; Hung CY
J Immunol; 2020 Jun; 204(12):3296-3306. PubMed ID: 32358020
[No Abstract] [Full Text] [Related]
34. Dendritic cell-based vaccine against coccidioides infection.
Awasthi S
Ann N Y Acad Sci; 2007 Sep; 1111():269-74. PubMed ID: 17363430
[TBL] [Abstract][Full Text] [Related]
35. Immunogenicity of a 48-kilodalton recombinant T-cell-reactive protein of Coccidioides immitis.
Kirkland TN; Thomas PW; Finley F; Cole GT
Infect Immun; 1998 Feb; 66(2):424-31. PubMed ID: 9453590
[TBL] [Abstract][Full Text] [Related]
36. A vaccine against coccidioidomycosis is justified and attainable.
Cole GT; Xue JM; Okeke CN; Tarcha EJ; Basrur V; Schaller RA; Herr RA; Yu JJ; Hung CY
Med Mycol; 2004 Jun; 42(3):189-216. PubMed ID: 15283234
[TBL] [Abstract][Full Text] [Related]
37. Coadministration of interleukin 12 expression vector with antigen 2 cDNA enhances induction of protective immunity against Coccidioides immitis.
Jiang C; Magee DM; Cox RA
Infect Immun; 1999 Nov; 67(11):5848-53. PubMed ID: 10531239
[TBL] [Abstract][Full Text] [Related]
38. Detecting serum antibodies to a purified recombinant proline-rich antigen of Coccidioides immitis in patients with coccidioidomycosis.
Orsborn KI; Galgiani JN
Clin Infect Dis; 1998 Dec; 27(6):1475-8. PubMed ID: 9868663
[TBL] [Abstract][Full Text] [Related]
39. Novel strategies to enhance vaccine immunity against coccidioidomycosis.
Cole GT; Hung CY; Sanderson SD; Hurtgen BJ; Wüthrich M; Klein BS; Deepe GS; Ostroff GR; Levitz SM
PLoS Pathog; 2013; 9(12):e1003768. PubMed ID: 24367252
[No Abstract] [Full Text] [Related]
40. Recombinant vaccines of a CD4+ T-cell epitope promote efficient control of Paracoccidioides brasiliensis burden by restraining primary organ infection.
Holanda RA; Muñoz JE; Dias LS; Silva LBR; Santos JRA; Pagliari S; Vieira ÉLM; Paixão TA; Taborda CP; Santos DA; Bruña-Romero O
PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005927. PubMed ID: 28938005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
